Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205192 · ClinicalTrials.gov registry record
Optimizing Cardiac Resynchronization
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 100
- Enrollment target
NCT00205192 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 100 participants.
The verdict
NCT00205192 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Cardiac resynchronization therapy shows great promise as a method to improve ventricular function in heart failure due to dilated cardiomyopathy. It is applied to patients with class III and IV symptomatic heart failure on optimal therapy. Typical entry criteria in the trials testing resynchronization have used the electrocardiogram and a prolonged electrocardiogram (ECG) QRS interval as criteria for dyssynchrony. This is recognized to be quite limited as a tool for identifying patients. Several new echocardiographic methods for identifying dyssynchrony have been proposed. The purpose of this study is to systematically examine these multiple echocardiographic measurement techniques in three conditions: 1. in the patient's native rhythm simulated by changing the pacing system to atrial pacing only; 2. in conventional dual chamber pacing (DDD mode); and 3. during biventricular pacing. All patients entered into this study will already have had a biventricular pacemaker placed.
Interventions
- PROCEDURE Cardiac resynchronization pacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2004-06 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00205192
The ClinicalTrials.gov registry entry for NCT00205192 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac resynchronization pacing is the first listed.
NCT00205192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00205192 about?
NCT00205192 is a clinical study titled "Optimizing Cardiac Resynchronization". Cardiac resynchronization therapy shows great promise as a method to improve ventricular function in heart failure due to dilated cardiomyopathy. It is applied to patients with class III and IV symptomatic heart failure on optimal therapy. Typical entry criteria in the trials testing resynchronizati...
What is the current status of trial NCT00205192?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2004-06. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00205192?
The interventions under investigation include: Cardiac resynchronization pacing (PROCEDURE).
Who is sponsoring clinical trial NCT00205192?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.